Results 41 to 50 of about 105,256 (302)
Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease [PDF]
, 2021 Background: Sarcopenia is a significant indicator of the severity of non-alcoholic fatty liver disease. We investigated whether sarcopenia could identify subgroups with different risk of liver fibrosis and atherosclerotic cardiovascular disease (ASCVD ...
안상훈 +6 more
core +1 more source
PLoS ONE, 2021 Sarcopenia is intricately related to aging associated diseases, such as neuropsychiatric disorders, oral status, and chronic diseases. Dementia and depression are interconnected and also related to sarcopenia.
Takeshi Endo +8 more
doaj +1 more source
A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction [PDF]
, 2022 Sarcopenia is a progressive and generalized loss of skeletal muscle mass and function. The prevalence of sarcopenia was reported to be up to 29% in older persons in the community healthcare setting.
Tolosa-Cubillos, Jorge Mauricio +4 more
core +1 more source
Frontiers in Medicine, 2021 Background: Little is known about whether sarcopenia predicts incident depressive symptoms in older adults. Using the nationally representative data from the China Health and Retirement Longitudinal Study (CHARLS), we conducted cross-sectional and ...
Ke Gao +8 more
doaj +1 more source
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40-79 years) [PDF]
, 2022 Background Age-related chronic low-grade inflammation (inflammaging) is one of the proposed mechanisms behind sarcopenia. However, findings regarding inflammatory markers in sarcopenic older adults are conflicting.
Casanueva Felipe F. +16 more
core +1 more source
Journal of Functional Morphology and KinesiologyBackground: Echo intensity (EI) has emerged as a promising and accessible tool for tracking changes in skeletal muscle quality; however, its utility during early-phase rehabilitation has not been studied. Using an observational cohort design, we examined
Matt S. Stock +5 more
doaj +1 more source
One‐year change in sarcopenia was associated with cognitive impairment among haemodialysis patients
Journal of Cachexia, Sarcopenia and Muscle, 2023 Background Our study aimed to evaluate change in sarcopenia, its defining components over 1 year follow‐up and investigate associations with subsequent cognitive decline, incident mild cognitive impairment (MCI) and dementia among patients undergoing ...
Yuqi Yang +3 more
doaj +1 more source
European Journal of Radiology, 2016 Sarcopenia is currently considered a geriatric syndrome increasing in older people. The consequences of sarcopenia - in terms of impaired mobility, limited self-sufficiency and disability - have been amply demonstrated, increasing the need to develop methods to identify muscle mass loss as early as possible.
SERGI, GIUSEPPE +4 more
openaire +4 more sources
Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS) [PDF]
The Global Leadership Initiative in Sarcopenia (GLIS) aims to standardize the definition and diagnostic criteria for sarcopenia into one unifying, common classification.
Woo, Jean +18 more
core +2 more sources
Design and analysis strategies for robust microbiome ageing research
FEBS Letters, EarlyView.The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source